 Hudson tells Bloomberg that AI carries potential not only for the drug business, but anyone waiting for treatments and cures. There's such a large amount of diseases that don't have medicines available for them because we simply have not had the computing power, the opportunity to deploy ourselves. And now we're at this next great revolution in science.